Hyacinth J Depamphilis is categorized under Internal Medicine Practitioners in Hanover, PA and active since 2005.
Hyacinth J Depamphilis was established in 2005, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Hyacinth J Depamphilis at the company’s single location by writing to 795 Cherry Tree Court # 3, Hanover, Pennsylvania PA 17331 or by phoning (925) 932-6465. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Hyacinth J Depamphilis |
Contact Person: | Hyacinth J Depamphilis |
Address: | 795 Cherry Tree Court # 3, Hanover, Pennsylvania 17331 |
Phone Number: | (925) 932-6465 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2005 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Practitioners |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
Hyacinth J Depamphilis was started in 2005 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Hyacinth J Depamphilis for inquiries that concern Hyacinth J Depamphilis by calling the company number (925) 932-6465, as your correspondence is most welcome. Additionally, the physical location of the single location of Hyacinth J Depamphilis can be found at the coordinates 39.815523,-76.964307 as well as the street address 795 Cherry Tree Court # 3 in Hanover, Pennsylvania 17331.
For its online presence, you may visit Hyacinth J Depamphilis’s website at and engage with its social media outlets through on Twitter and on Facebook.